Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models

Nicha Wongjarupong, Gabriela M. Negron-Ocasio, Roongruedee Chaiteerakij, Benyam D. Addissie, Essa A. Mohamed, Kristin C. Mara, William S. Harmsen, J. Paul Theobald, Brian E. Peters, Joseph G. Balsanek, Melissa M. Ward, Nasra H. Giama, Sudhakar K. Venkatesh, Denise M. Harnois, Michael R. Charlton, Hiroyuki Yamada, Alicia Algeciras-Schimnich, Melissa R. Snyder, Terry M. Therneau, Lewis R. Roberts

Research output: Contribution to journalReview article

6 Scopus citations

Fingerprint Dive into the research topics of 'Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models'. Together they form a unique fingerprint.

Medicine & Life Sciences